alogliptin benz/metformin HCl
12.5-1000, 12.5-500MG — Tablet
Also known as:
KAZANO
ALOGLIPTIN-METFORMIN
Coverage by Insurer
Informational only — Coverage rules change frequently; verify tier placement and restrictions with your plan or pharmacy before acting.
NC Medicaid PDL
2 plansTRICARE
2 plans| Plan | Tier | Prior Auth | Step Therapy | Quantity Limit | Restrictions |
|---|---|---|---|---|---|
|
TRICARE Uniform Formulary 2026
via alogliptin-metformin |
Tier 3 - Non-Formulary | — | ✓ | — | ST Step therapy: 9DPP-4 INHIBITORS SECONDARY RULE- SEL DPP-4 INHIBITORS REQ PA W/O SELECT ANTI-HYPREGLYCEMIC |
|
TRICARE Uniform Formulary 2026
via Kazano |
Tier 3 - Non-Formulary | — | ✓ | — | ST Step therapy: 9DPP-4 INHIBITORS SECONDARY RULE- SEL DPP-4 INHIBITORS REQ PA W/O SELECT ANTI-HYPREGLYCEMIC |